SCM
GILD icon

Silvant Capital Management’s Gilead Sciences GILD Stock Holding History

Silvant Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$197K Hold
1,411
– – 0.01% 190
2025
Q4 		$173K Hold
1,411
– – 0.01% 194
2025
Q3 		$157K Hold
1,411
– – 0.01% 197
2025
Q2 		$156K Hold
1,411
– – 0.01% 192
2025
Q1 		$158K Hold
1,411
– – 0.01% 187
2024
Q4 		$130K Hold
1,411
– – 0.01% 207
2024
Q3 		$118K Hold
1,411
– – 0.01% 211
2024
Q2 		$96.8K Hold
1,411
– – ﹤0.01% 212
2024
Q1 		$103K Hold
1,411
– – ﹤0.01% 215
2023
Q4 		$114K Hold
1,411
– – 0.01% 203
2023
Q3 		$106K Hold
1,411
– – 0.01% 202
2023
Q2 		$109K Hold
1,411
– – 0.01% 202
2023
Q1 		$117K Hold
1,411
– – 0.01% 192
2022
Q4 		$121K Hold
1,411
– – 0.01% 191
2022
Q3 		$87K Hold
1,411
– – 0.01% 263
2022
Q2 		$87K Hold
1,411
– – 0.02% 222
2022
Q1 		$84K Sell
1,411
-24,463
-95% -$1.56M 0.02% 242
2021
Q4 		$1.88M Sell
25,874
-1,460
-5% -$101K 0.32% 70
2021
Q3 		$1.91M Sell
27,334
-2,472
-8% -$174K 0.34% 71
2021
Q2 		$2.05M Sell
29,806
-672
-2% -$44.9K 0.32% 75
2021
Q1 		$1.97M Hold
30,478
– – 0.34% 74
2020
Q4 		$1.78M Sell
30,478
-148
-0.5% -$8.93K 0.3% 79
2020
Q3 		$1.94M Sell
30,626
-536
-2% -$37.2K 0.36% 72
2020
Q2 		$2.4M Hold
31,162
– – 0.43% 61
2020
Q1 		$2.33M Hold
31,162
– – 0.51% 53
2019
Q4 		$2.02M Sell
31,162
-168
-0.5% -$10.9K 0.37% 76
2019
Q3 		$1.99M Sell
31,330
-289
-0.9% -$18.9K 0.39% 70
2019
Q2 		$2.14M Sell
31,619
-258
-0.8% -$17K 0.38% 74
2019
Q1 		$2.07M Sell
31,877
-180
-0.6% -$12K 0.37% 73
2018
Q4 		$2.01M Sell
32,057
-36,438
-53% -$2.55M 0.4% 79
2018
Q3 		$5.29M Sell
68,495
-466
-0.7% -$35.2K 0.65% 52
2018
Q2 		$4.88M Buy
68,961
+861
+1% +$60.8K 0.6% 62
2018
Q1 		$5.13M Buy
+68,100
New +$5.41M 0.66% 59

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Silvant Capital Management's GILD Position: Q1 2026 in Review

Silvant Capital Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,411 shares worth $197K. The position accounts for 0.01% of the portfolio, ranked #190.

Silvant Capital Management first reported a position in GILD in Q1 2018 and has held it in 33 quarters since. The position peaked at $5.29M in Q3 2018. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Silvant Capital Management held 1,411 shares of Gilead Sciences worth $197K as of Q1 2026.
  • Silvant Capital Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.01% of Silvant Capital Management's portfolio in Q1 2026, its #190 holding.
  • Silvant Capital Management first reported a position in Gilead Sciences in Q1 2018 and has held it in 33 quarters since.
  • Silvant Capital Management's Gilead Sciences position peaked at $5.29M in Q3 2018.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.